Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Physical exercise contributes to cisplatin-induced nephrotoxicity protection with decreased CD4+ T cells activation.
Mol Immunol. 2018 Sep;101:507-513. doi: 10.1016/j.molimm.2018.08.014. Epub 2018 Aug 22.
Mol Immunol. 2018.
PMID: 30144701
Long-term aerobic exercise protects against cisplatin-induced nephrotoxicity by modulating the expression of IL-6 and HO-1.
Miyagi MY, Seelaender M, Castoldi A, de Almeida DC, Bacurau AV, Andrade-Oliveira V, Enjiu LM, Pisciottano M, Hayashida CY, Hiyane MI, Brum PC, Camara NO, Amano MT.
Miyagi MY, et al.
PLoS One. 2014 Oct 1;9(10):e108543. doi: 10.1371/journal.pone.0108543. eCollection 2014.
PLoS One. 2014.
PMID: 25272046
Free PMC article.
Item in Clipboard
Identification of ANLN as ETV6 partner gene in recurrent t(7;12)(p15;p13): a possible role of deregulated ANLN expression in leukemogenesis.
Campregher PV, Pereira WO, Lisboa B, Puga R, Helman R, Miyagi M, da Mata EH, Datoguia TS, Velloso ED, Bacal NS, Ross JS, Ali S, Miller V, Costa FF, Hamerschlak N, Santos FP.
Campregher PV, et al.
Mol Cancer. 2015 Nov 19;14:197. doi: 10.1186/s12943-015-0471-5.
Mol Cancer. 2015.
PMID: 26584717
Free PMC article.
Item in Clipboard
Optimizing adjuvant inhaled chemotherapy: Synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach.
Miyagi MYS, de Oliveira Faria R, de Souza GB, Lameu C, Tagami T, Ozeki T, Bezzon VDN, Yukuyama MN, Bou-Chacra NA, de Araujo GLB.
Miyagi MYS, et al.
Int J Pharm. 2023 Sep 25;644:123324. doi: 10.1016/j.ijpharm.2023.123324. Epub 2023 Aug 15.
Int J Pharm. 2023.
PMID: 37591475
Item in Clipboard
The lack of PI3Kγ favors M1 macrophage polarization and does not prevent kidney diseases progression.
Amano MT, Castoldi A, Andrade-Oliveira V, Latancia MT, Terra FF, Correa-Costa M, Breda CNS, Felizardo RJF, Pereira WO, da Silva MB, Miyagi MYS, Aguiar CF, Hiyane MI, Silva JS, Moura IC, Camara NOS.
Amano MT, et al. Among authors: miyagi mys.
Int Immunopharmacol. 2018 Nov;64:151-161. doi: 10.1016/j.intimp.2018.08.020. Epub 2018 Aug 31.
Int Immunopharmacol. 2018.
PMID: 30176533
Item in Clipboard
Cite
Cite